AUA Live Sunday (2020)

AUA Live is a virtual meeting and will include 65 sessions with over 165 speakers, panelists and moderators. Vendors have been selected to schedule and record the sessions in advance and provide the platform for AUA Live. The “live” component will consist of moderators responsible for responding to the Live Chat feedback and questions.


The American Urological Association would like to thank the following companies for providing independent educational grants in support of AUA Live:

  • Astellas
  • AstraZeneca
  • Bristol-Myers Squibb
  • Intuitive
  • Lumenis, Inc.
  • Merck
  • Pfizer, Inc.
  • Photocure Inc.
  • PROCEPT BioRobotics
  • Sanofi Genzyme
  • Teleflex
  • Zhuhai Pusen Medical Technology Co., Ltd.

Target Audience

  • Urologist
  • Resident
  • Advanced Practice Provider (Nurse Practitioners & Physician Assistants)

Learning Objectives

At the conclusion of the AUA Live program, participants will be able to:

  1. Describe recent developments in the medical and surgical management of urology patients.
  2. Identify new technologies for the treatment of urologic conditions.
  3. Integrate the latest guidelines on the management of urological diseases into their practice.
Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Non-Physician Participation
Course opens: 
Course expires: 
Part of: 

Sunday, June 28, 2020  

Theater One

10 – 10:30 a.m.
Crossfire: Controversies in Urology: Telemedicine is Good for Patients and Providers in Sexual Medicine
Moderator: Gerald Brock, MD
Debaters-Pro: Irwin Goldstein, MD; Nelson Bennett, MD
Debater-Con: Arthur Burnett, MD; Serge Carrier, MD

10:30 – 10:50 a.m.
Panel Discussion: Infection and Urologic Implants
Moderator: Daniel Shoskes, MD
Foley Catheters and Biofilm: Florian Wagenlehner, MD
Urine cultures and AUS placement: Hadley Wood, MD
Infection and Encrustation of Stents: Kymora Scotland, MD

10:50 – 11:05 a.m.
State-of-the-Art Lecture: How to Painlessly Manage Chronic Orchalgia
Presenter: Keith Jarvi, MD

11:05 – 11:30 a.m.
Panel Discussion: Consumerism of Erectile Dysfunction
Moderator: Tobias Kohler, MD
Online telemedicine: Alex Pastuszak, MD, PhD
Shockwave: Tom Lue, MD
Penile Enhancement: Run Wang, MD, FACS
T-shot clinics: Andrew McCullough, MD

11:30 – 11:45 a.m.
State-of-the-Art Lecture: Update on Clinical Trials on Restorative Therapies for Erectile Dysfunction
Presenter: Trinity Bivalacqua, MD

11:45 a.m. – 12:10 p.m.
Panel Discussion: Peyronie’s Disease Management: Tips & Tricks
Moderator: Lawrence Hakim, MD
CCH: Jesse Mills, MD
Intron A: Wayne Hellstrom, MD
Plication: Billy Cordon, MD
Grafting: William Brant, MD
IPP: Rafael Carrion, MD

12:10 – 12:25 p.m.
State-of-the-Art Lecture: Painful, Smelly, Discolored, or Blood Ejaculation: Best Practices
Presenter: Landon Trost, MD

12:25 – 1 p.m.

1:25 – 1:50 p.m.
Panel Discussion: Multidisciplinary Discussion on Fertility, Hypogonadism, and Sexual Function for Testis Cancer Patients
Moderator: Mohit Khera, MD
Management of Testis Cancer: Andrew Stephenson, MD
Fertility Preservation: Robert Brannigan, MD
Hypogonadism/Sexual Function: John Mulhall, MD

1:50 – 2:10 p.m.
Surgical Techniques: Tips & Tricks: Excision and Grafting for Peyronie’s Disease
Surgeon: Laurence Levine, MD

2:10 – 2:25 p.m.
AUA Guidelines 2020: Disorders of Ejaculation
Presenter: Alan Shindel, MD

2:25 – 2:50 p.m.
Panel Discussion: Is Radiotherapy the Devil's Work?
Moderator: Kenneth Angermeier, MD
Panelists: Tamsin Greenwell, MD; Sean Elliott, MD; Francisco Martins, MD

2:50 – 3:20 p.m.
Crossfire: Controversies in Urology: Robotic Reconstruction: Almost as Good as the Real Thing
Moderator: Bradley Erickson, MD, MS, FACS
Panelists: John Kelly, MD; Benjamin N. Breyer, MD, FACS; Daniel Eun, MD; Brian J. Flynn, MD

3:20 – 3:50 p.m.
Panel Discussion: Bulbar Urethral Strictures 101: A Review of the Guidelines and Basic Management Options for Bulbar Urethral Strictures in a Case-based Format
Moderator: Dmitry Nikolavsky, MD
Panelists: Amanda Chung, MD; Matthias D. Hofer, MD, PhD; Lindsey Hampson, MD; Bryan Voelzke, MD

3:50 – 4:20 p.m.
Surgical Techniques: Ureteral Reconstruction: Kidney to Bladder
Moderator: Jill C. Buckley, MD
Panelists: Judith C. Hagedorn, MD; Boyd R. Viers, MD; Jeremy L. Ockrim, MD; Lee C. Zhao, MD

4:20 – 4:25 p.m.
Closing Remarks
AUA Secretary: John Denstedt, MD, FACS

Theater Two

10 – 10:30 a.m.
Panel Discussion: Status of Robotic Surgery in Pediatric Urology 2020
Moderator: Christina Kim, MD
Upper Tract: Pasquale Casale, MD
Lower Tract: Chester Koh, MD

10:30 – 11 a.m.
Crossfire: Controversies in Urology: Neonatal Torsion
Moderator: David Diamond, MD
Immediate Surgery: Gerry Mingin, MD
Delayed Surgery: Michael Leonard, MD

11 – 11:30 a.m.
State-of-the-Art Lecture: Current Urologic Management of CAH
Presenter: Richard Rink, MD

11:30 – 11:50 a.m.
John Duckett Memorial Lecture: Effects of Cancer Treatment in Children into Adulthood
Presenter: Daniel Green, MD

11:50 a.m. – 12:20 p.m.
COVID-19 Panel Discussion
COVID Vaccine: Reality or Not?: Presenter: Ashish Kamat, MD
Risk of COVID in Urology Practice Settings: Presenter: Jennifer Robles, MD
Telemedicine: Christopher Saigal, MD

12:20 – 12:35 p.m.
AUA Guidelines 2020: BPH
Presenter: Steven Kaplan, MD

12:35 – 12:50 p.m.
State-of-the-Art Lecture: Nocturia in the Elderly
Presenter: Alan Wein, MD

12:50 – 1:50 p.m.
Surgical Techniques: Tips & Tricks: Minimally Invasive Treatments for BPH/LUTS
Aquablation: Steven Kaplan, MD
Prostatic Urethral Lift In-office Procedure: Brian Mazzarella, MD
Water Vapor Therapy for BPH patients: Kevin McVary, MD
Temporary Implantable Nitonol Device: Dean Elterman, MD

1:50 – 2:05 p.m.
State-of-the-Art Lecture: Probiotics and Urology
Presenter: Jeremy Burton, MD

2:05 – 2:20 p.m.
State-of-the-Art Lecture: Future of Neuromodulation—Rechargeable, PTNS Implantable, What else?
Presenter: Phillip van Kerrebroeck, MD

2:20 – 2:50 p.m.
Crossfire: Controversies in Urology: Are Urodynamics needed in the Workup of Post-prostatectomy Incontinence?
Moderator: Jaspreet Sandhu, MD
Debaters-Con: Arthur Mourtzinos, MD; O. Lenaine Westney, MD
Debaters-Pro: Timothy Boone, MD; Craig Comiter, MD

2:50 – 3:20 p.m.
Second Opinion Cases: How to Manage a 65-year-old Man with Bothersome LUTS and Underactive Bladder
Moderator: Henry Lai, MD
Panelists: Jason Gilleran, MD; Alvaro Lucioni, MD; Toby Chai, MD; Kyu-Sung Lee, MD

3:20 – 3:50 p.m.
AUA Guidelines Case-Based Panel: Stress Urinary Incontinence
Moderator: Kathleen Kobashi, MD, FACS, FPMRS
Panelists: Cristiano M. Gomes, MD; E. Ann Gormley, MD; J. Christian Winters, MD

3:50 – 3:55 p.m.
Closing Remarks
AUA Secretary: John Denstedt, MD

Theater Three (Non-CME)

10 – 11 a.m.
Expanding kidney-sparing options for patients with low-grade upper tract urothelial cancer
Speaker: Karim Chamie, MD, MSHS
Description: Please join us for Dr. Karim Chamie’s presentation on a new and innovative FDA-approved treatment for patients with low-grade upper tract urothelial cancer. This presentation will highlight the benefits of a kidney-sparing option for low-grade utuc, explore the clinical profile and review the safety data associated with this new treatment option. Following the presentation, Dr. Chamie will be holding a live Q&A, which will be moderated by Dr. Mark Schoenberg.

Sponsored by: UroGen Pharma

11 a.m – Noon
Androgen Deprivation Therapy (ADT): Reducing Morbidity and Improving Outcome
Speaker: Laurence Klotz, MD
Description: Dr. Laurence Klotz will discuss the adverse effects of androgen deprivation therapy (ADT) treatment for prostate cancer and approaches to monitor and reduce these side effects. This presentation will also highlight the importance of monitoring testosterone levels in men receiving ADT. He will compare intermittent versus continuous ADT and factors to consider when choosing ADT. Finally, Dr. Klotz will examine ADTs role in the ARAT era. This product theater will be held on June 28, 2020 from 11 a.m. to Noon.

Sponsored by: AbbVie

12 – 12:30 p.m. and 12:30 – 1 p.m.
A Treatment Approach for Certain Patients with High Risk Non-Muscle Invasive Bladder Cancer
Speaker: Tom Jayram, MD – Director, Advanced Therapeutics Center at Urology Associates , Nashville, TN
Description: This content will review the features of non-muscle invasive bladder cancer, evaluate the clinical data on a treatment option for certain patients with high-risk non-muscle invasive bladder cancer, and understand the safety data associated with this treatment option for certain patients with high-risk non- muscle invasive bladder cancer.

This program is a promotional activity and is not approved for continuing medical education (CME) credit and is not designed to meet any training and/or educational requirements. This program is for healthcare professionals of the United States, its territories, and Puerto Rico only. The content of this program and opinions expressed by the presenters are those of the sponsor or presenters and not of the American Urological Association.

Sponsored by: Merck

1 – 2 p.m.
Aquablation Therapy: Reimagining Conventions in BPH Surgical Treatment
Speakers: Claus Roehrborn, MD; Peter Gilling, CNZM, MD (Otago), FRACS; Kevin Zorn, MD, FRCSC, FACS; Neil Barber, FRCS (Urol); Lewis Kriteman, MD, FACS
Description: The surgical treatment of BPH is rapidly evolving. Come listen to global thought-leaders discuss the most pivotal questions and considerations in BPH surgery today. Don't miss this opportunity to engage in the discussion through a live Q&A session with the faculty.

Sponsored by: Procept BioRobotics Corporation

2 – 3 p.m.
Finally, an Oral Testosterone Replacement Therapy for Men with Hypogonadism
Speaker: Culley Carson III, MD - University of North Carolina at Chapel Hill
Description: Join us for an overview of an FDA-approved and available oral testosterone replacement therapy. During this program, an expert will discuss the history and challenges of TRTs, and the pathway to approval for this oral option, as well as its safety and efficacy profiles.

Sponsored by: Clarus Therapeutics, Inc

3 – 4 p.m.
The MOSES Technology – A proven innovation for urinary stones and BPH treatments
Speakers: Mantu Gupta MD – Professor of Urology, Icahn School of Medicine at Mount Sinai, New York, NY; Roger Sur MD – Professor of Urology, UC San Diego, CA; Tim Large MD – Assistant Professor of Urology, Indiana University, IN
Description: The MOSES Technology is redefining urology care worldwide. With 20% faster procedures and up to 2.6 greater fragmentation rate in lithotripsy, as well as 15% faster enucleation and over 90% of patients discharged on the day of surgery – MOSES provides a proven and ongoing innovation for Urology professionals.

Sponsored by: Lumenis

All persons in a position to control the content of this educational activity (i.e., activity planners, speakers, moderators) were required to disclose to the provider any relevant financial relationships with any commercial interest.    

PDF iconView Planning Committee Disclosures

PDF iconView Speaker and Moderator Disclosures

Note: Only individuals that attended the Live Program on Sunday, June 28, 2020 may claim credit for their participation.  


The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The American Urological Association designates this live activity for a maximum of 6.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.


It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.


All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.


All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty


The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

AUA Participant Information and Policies


The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.


The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.


Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Non-Physician Participation
Please login or register to take this course.

Recordings from the AUA Live may be viewed by clicking the "Take Course" button.

*Note: Video recordings will be available until Monday, June 28, 2021. 

If you attended the live program, you may also click the "Take Course" button to complete the evaluation and claim credit.

*Note: Only individuals that attended the live course are eligible to claim credit.